Scars Clinical Trial
Official title:
A Pilot Study Comparing Cutaneous Scarring When Scalpel Versus Cautery is Used to Make Skin Incisions
Cutaneous scarring after elective surgery is a concern for surgeons of all types, perhaps even more so to plastic surgeons. Cautery is often used on the "cut" setting to make or extend incisions; however very few studies have looked at the results of these scars. The investigators' study aims are to compare standard scalpel incisions versus cautery incisions and to objectively compare the resultant scars in a prospective, randomized, controlled fashion.
Rationale: Most surgeons at some point have used the "cut" setting on a cautery device to
make or extend an incision. Anecdotally, there does not appear to be a noticeable difference
in the scarring. This opinion, however is not shared by all surgeons.
Review of the literature reveals a paucity of evidence supporting the use of cutting cautery
vs. standard, scalpel incision. A study that objectively, prospectively, and randomly
compares the scars between these two methods has the potential to alter the doctrine of
scalpel incisions, potentially saving money, and allowing a safer operating room environment
(one free of scalpels in some cases).
Objectives: To objectively compare the cutaneous scars resulting from scalpel versus cutting
cautery incisions using a subjective and objective scar measurement tool.
Methodology:
Research Design: This study will be a Blinded, Prospective, Randomized Controlled Trial.
Research Participants:
Comparison Information: The patient will have ½ of the incision performed with standard
scalpel incision, and the contralateral ½ of the incision with cutting cautery incision. The
sides will be randomized using a random number generator. For purposes of this study, the
right side of the incision is defined as the patient's right side and the left side of the
incision is defined as the patient's left side.
Criteria for Discontinuation: The study will be discontinued if it becomes obvious that the
cautery ½ of the incision develops increased complications relating to infections, wound
breakdown, or scarring.
Observations: The patients will follow up after surgery for evaluations at 2 weeks, 3
months, 6 months, and 12 months. Patients, physicians and a blinded independent observer
will evaluate the scars using a visual analogue scale at 2 weeks, 3 months, 6 months and 12
months. Also, at 12 months, the Patient and Observer Scar Assessment Tool will be used to
evaluate all scars in order to provide objective and subjective scar evaluation. The
subject, surgeon and blinded observer will complete this evaluation.
Sample Size: 10 patients will be enrolled in our study. The data gathered from this pilot
study should provide us with the data necessary to perform a power and sample size
calculation for a future randomized controlled trial.
Date Management and Analysis: At postoperative follow up visits (2 weeks +/- 4 days, 3
months +/- 2 weeks, 6 months +/- 2 weeks), the patient, physician and independent observer
will evaluate the scar subjectively using a visual analogue scale measuring 10 cm in length.
One side of the scale (the side nearest 0) will imply the poorest scar imaginable; the
opposite side will represent the best. Measurements will be taken regarding width, and
observations regarding erythema and pigment will be noted.
At the 12 month postoperative follow up, the Patient and Observer Scar Assessment Tool will
be used to compare the scars in order to provide both subjective and objective data.
Ethical Considerations
Protection of Human Subjects: Approval from the IRB will be obtained prior to beginning this
study. All investigators have met federal and institutional educational requirements for
Human Subjects Protection.
Patients will be offered scar revisions at no additional costs to the patient on the "test"
side. These scar revisions will be offered at 1 year if necessary.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04806594 -
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
|
N/A | |
Completed |
NCT01700595 -
Preexpanded Perforator Flaps in Children
|
N/A | |
Recruiting |
NCT03782038 -
Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars
|
N/A | |
Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
Not yet recruiting |
NCT02590042 -
Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction
|
Phase 1 | |
Completed |
NCT01932359 -
Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study
|
N/A | |
Completed |
NCT01091181 -
The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar
|
N/A | |
Unknown status |
NCT00969475 -
The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure
|
N/A | |
Recruiting |
NCT06021275 -
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
|
N/A | |
Recruiting |
NCT02195063 -
Survey Study for Pain Management, Wound Care, Scar Care or UDT
|
Phase 4 | |
Not yet recruiting |
NCT04593706 -
Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)
|
N/A | |
Recruiting |
NCT05847530 -
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
|
N/A | |
Withdrawn |
NCT01350739 -
The Umbilical Access in Laparoscopic Surgery
|
N/A | |
Completed |
NCT02145130 -
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
|
Phase 1 | |
Completed |
NCT01358838 -
Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars
|
N/A | |
Completed |
NCT03880058 -
Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
|
Phase 1/Phase 2 | |
Recruiting |
NCT05528328 -
Post-surgical Scars After the Use of CACIPLIQ20
|
Phase 3 | |
Completed |
NCT00450775 -
Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars
|
Phase 4 | |
Completed |
NCT00580736 -
Optical Clearing of the Skin in Conjunction With Laser Treatments
|
Phase 1 | |
Withdrawn |
NCT04269317 -
Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars
|
N/A |